Paul Haeder, MD
Sports Medicine · Bellingham, WANPI 1912291113
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (35.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Arthrex at 57.7% of the total. Reporting peaked in 2022 at $2,577 and has fallen 95.8% since, to $108 in 2025.
Across 50 payments — averaging $78.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$2K
- Summit Surgical Corp.$817
- Si-bone, Inc.$169
- Conformis, Inc.$108
- Bioventus LLC$100
- Abbott$74
- plus $395 from 13 others
What the payments were for
- Travel & lodging$1,34134%
- Food & beverage$1,38635%
- Education$1,20031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 20 | $2,265 |
| Summit Surgical Corp. | 3 | $817 |
| Si-bone, Inc. | 4 | $169 |
| Conformis, Inc. | 3 | $108 |
| Bioventus LLC | 4 | $100 |
| Abbott | 1 | $74 |
| Orthofix Medical, Inc. | 2 | $56 |
| Invictus Surgical Incorporated | 1 | $47 |
| Sanara Medtech Inc. | 1 | $41 |
| Avanos Medical | 2 | $41 |
| DJO, LLC | 1 | $39 |
| Stryker | 1 | $37 |
| Fidia Pharma USA Inc. | 1 | $34 |
| Davol Inc. | 1 | $22 |
| Vericel Corporation | 1 | $18 |
| Merck | 1 | $18 |
| Smith+Nephew | 1 | $15 |
| KCI USA, Inc. | 1 | $14 |
| Zimmer Biomet | 1 | $12 |
How this compares
$3,927 in reported general payments places this provider in the 75th percentile of 132 sports medicine providers in Washington.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 25 | $669 |
| Ondansetron Hcl | 56 | $153 |
| Ketorolac Tromethamine | 11 | $152 |
| Meloxicam | 21 | $65 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Bellingham
- Christopher van HofwegenBellingham$756
- Justis StolzBellingham$743
- Geoffrey HiggsProsser$569K
- Nicholas KennedyYakima$112K
- Nicholas VaudreuilEverett$49K
- Adam PourchoSeattle$38K
- Christopher WahlIssaquah$37K
- Nicholas WilcoxMarysville$36K
- Mathew TaylorPullman$36K
- Brandon NudelmanBellevue$32K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.